phenylalanine and Brain Ischemia

phenylalanine has been researched along with Brain Ischemia in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (11.11)18.2507
2000's4 (44.44)29.6817
2010's3 (33.33)24.3611
2020's1 (11.11)2.80

Authors

AuthorsStudies
Feng, JH; Hong, Y; Hu, XL; Long, H; Lv, XY; Wang, H; Wang, JJ; Wang, R; Xiong, F; Zhang, YH1
Cao, J; Chen, S; Liu, W; Luo, X; Qiao, Y; Sun, M; Wen, A; Yang, Z; Zhao, X1
Ormstad, H; Sandvik, L; Verkerk, R1
Rosenberg, GA; Walker, EJ1
Baĭsa, AE; Burov, SV; Chefu, SG; Leko, MV; Veselkina, OS; Vlasov, TD1
Pfefferkorn, T; Rosenberg, GA1
Hatazawa, J; Iida, H; Inugami, A; Itoh, H; Kanno, I; Miura, S; Murakami, M; Ogawa, T; Okudera, T; Shimosegawa, E1
Asahi, K; Asahi, M; del Zoppo, GJ; Fini, ME; Jung, JC; Lo, EH1
Lo, EH; Sumii, T1

Other Studies

9 other study(ies) available for phenylalanine and Brain Ischemia

ArticleYear
4-Trifluoromethyl-(E)-cinnamoyl]-L-4-F-phenylalanine acid exerts its effects on the prevention, post-therapeutic and prolongation of the thrombolytic window in ischemia-reperfusion rats through multiple mechanisms of action.
    Pharmacological research, 2022, Volume: 178

    Topics: Animals; Brain Ischemia; Fibrinolytic Agents; Infarction, Middle Cerebral Artery; Ischemia; Ischemic Stroke; Neuroprotective Agents; Phenylalanine; Rats; Reperfusion; Reperfusion Injury

2022
Neuroprotection of hydroxysafflor yellow A in experimental cerebral ischemia/reperfusion injury via metabolic inhibition of phenylalanine and mitochondrial biogenesis.
    Molecular medicine reports, 2019, Volume: 19, Issue:4

    Topics: Animals; Behavior, Animal; Brain Ischemia; Chalcone; Disease Models, Animal; Energy Metabolism; Gene Expression Regulation, Enzymologic; Mice; Mitochondria; Neurons; Neuroprotective Agents; Organelle Biogenesis; Oxidative Stress; PC12 Cells; Phenylalanine; Quinones; Rats; Reperfusion Injury; Treatment Outcome

2019
Serum Phenylalanine, Tyrosine, and their Ratio in Acute Ischemic Stroke: on the Trail of a Biomarker?
    Journal of molecular neuroscience : MN, 2016, Volume: 58, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Brain Ischemia; Case-Control Studies; Female; Humans; Male; Middle Aged; Phenylalanine; Stroke; Tyrosine

2016
TIMP-3 and MMP-3 contribute to delayed inflammation and hippocampal neuronal death following global ischemia.
    Experimental neurology, 2009, Volume: 216, Issue:1

    Topics: ADAM Proteins; ADAM17 Protein; Animals; Apoptosis; Brain Ischemia; Disease Models, Animal; Encephalitis; Enzyme Inhibitors; Gene Expression Regulation, Enzymologic; Gliosis; Hippocampus; Matrix Metalloproteinase 3; Matrix Metalloproteinase Inhibitors; Mice; Mice, Inbred C57BL; Mice, Knockout; Nerve Degeneration; Neuroprotective Agents; Phenylalanine; Receptors, Tumor Necrosis Factor, Type I; Reperfusion Injury; Thiophenes; Tissue Inhibitor of Metalloproteinase-3; Tumor Necrosis Factor-alpha

2009
[Amides of creatine: perspectives of neuroprotection].
    Rossiiskii fiziologicheskii zhurnal imeni I.M. Sechenova, 2011, Volume: 97, Issue:7

    Topics: Amides; Animals; Brain Ischemia; Creatine; Female; gamma-Aminobutyric Acid; Glycine; Hemodynamics; Image Processing, Computer-Assisted; Infarction, Middle Cerebral Artery; Injections, Intraperitoneal; Injections, Intravenous; Ischemic Attack, Transient; Male; Microscopy; Microtomy; Models, Animal; Neuroprotective Agents; Phenylalanine; Rats; Rats, Wistar; Tetrazolium Salts; Tyrosine

2011
Closure of the blood-brain barrier by matrix metalloproteinase inhibition reduces rtPA-mediated mortality in cerebral ischemia with delayed reperfusion.
    Stroke, 2003, Volume: 34, Issue:8

    Topics: Animals; Blood-Brain Barrier; Brain; Brain Ischemia; Disease Models, Animal; Drug Administration Schedule; Enzyme Inhibitors; Infarction, Middle Cerebral Artery; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Matrix Metalloproteinases; Phenylalanine; Rats; Rats, Wistar; Recombinant Proteins; Reperfusion; Sucrose; Survival Rate; Thiophenes; Time Factors; Tissue Plasminogen Activator; Treatment Outcome; Water

2003
Accumulation of L-[2-(F-18)]fluorophenylalanine in peri-infarct area in a patient with acute cerebral infarction.
    Annals of nuclear medicine, 1994, Volume: 8, Issue:3

    Topics: Aged; Biological Transport, Active; Blood-Brain Barrier; Brain Ischemia; Cerebral Infarction; Female; Fluorine Radioisotopes; Humans; Phenylalanine; Tomography, Emission-Computed; Visual Fields

1994
Role for matrix metalloproteinase 9 after focal cerebral ischemia: effects of gene knockout and enzyme inhibition with BB-94.
    Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2000, Volume: 20, Issue:12

    Topics: Animals; Brain; Brain Ischemia; Male; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Mice; Mice, Inbred Strains; Mice, Knockout; Neuroprotective Agents; Phenylalanine; Protease Inhibitors; Stroke; Thiophenes; Transcription, Genetic

2000
Involvement of matrix metalloproteinase in thrombolysis-associated hemorrhagic transformation after embolic focal ischemia in rats.
    Stroke, 2002, Volume: 33, Issue:3

    Topics: Animals; Blood Flow Velocity; Brain; Brain Ischemia; Cerebral Hemorrhage; Cerebrovascular Circulation; Disease Models, Animal; Enzyme Inhibitors; Intracranial Embolism; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Matrix Metalloproteinases; Phenylalanine; Rats; Rats, Inbred SHR; Sodium, Dietary; Survival Rate; Thiophenes; Thrombolytic Therapy; Tissue Plasminogen Activator

2002